Bleomycin Hydrochloride

盐酸博莱霉素

Report date: 2024/04/25 10:23:43
NME

Base Information

Drug NameBleomycin Hydrochloride
Drug Alias Namebleomicinableomycinum
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsOsteitis DeformansVulvar NeoplasmsUterine Cervical Neoplasms +[12] 
Global Approved IndicationsUterine Cervical NeoplasmsLung NeoplasmsSkin Neoplasms +[10] 
Approved Indications in ChinaNeoplasms
Original Approved Country/TerritoryJapan
Original Approved Date1968/12/16
Country/TerritoryItalyMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesFondazione Policlinico Universitario Agostino Gemelli Irccs
Inactive CompaniesN/A
Active IndicationsOsteitis DeformansVulvar NeoplasmsUterine Cervical Neoplasms +[12] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank